Synergistic pharmaceutical combination for the prevention or treatment of diabetes
US7635674B2 · kind B2 · utility
0Cited by
7References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2002 |
| Grant date | Dec 22, 2009 |
| Priority date | — |
| Expiry date | Sep 12, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention refers to a synergistic pharmaceutical combination which comprises (a) a first pharmaceutical composition containing an antidiabetic or anti-hyperlipidemic active agent and one or more conventional carrier(s), and (b) a second pharmaceutical composition containing a hydroximic acid derivative of the formula I and one or more conventional carrier(s). The pharmaceutical combination is suitable for the prevention or treatment of, among others, diabetes mellitus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.